2024-10-27 - Analysis Report
## Thermo Fisher Scientific Inc. (TMO) Stock Analysis Report

**Company Overview:** Thermo Fisher Scientific Inc. is a leading provider of scientific instruments, reagents, consumables, software, and services for research, analysis, discovery, and diagnostics.

**Performance Analysis:**

**1.  Performance vs. S&P 500 (VOO):**

*   **Cumulative Return (TMO):** 218.48%
*   **Cumulative Return (VOO):** 135.48%
*   **Difference:** 83.00%
*   **Relative Divergence:** 38.8 (This means that TMO's performance is currently at the 38.8th percentile relative to its historical performance compared to VOO.)

**2.  Recent Price Movement:**

*   **Last Price:** 554.33
*   **5-Day Moving Average:** 583.47
*   **20-Day Moving Average:** 597.74
*   **60-Day Moving Average:** 605.37

**3.  Technical Indicators:**

*   **RSI:** 27.0 (Indicates a possible oversold condition)
*   **PPO:** -0.62 (Indicates a potential downward trend)
*   **Delta_Previous_Relative_Divergence:** -16.87 (Indicates a recent short-term downward trend)
*   **Expected Return:** 47.06% (Expected long-term (2+ years) excess return compared to S&P 500)

**4.  Recent Earnings and Outlook:**

| Date       | EPS       | Revenue        |
| :-------- | :-------- | :-------------- |
| 2024-08-02 | 4.05      | 10.54 B$       |
| 2024-05-03 | 3.47      | 10.35 B$       |
| 2023-11-03 | 4.44      | 10.57 B$       |
| 2023-08-04 | 3.53      | 10.69 B$       |
| 2024-08-02 | 3.53      | 10.69 B$       |

*   The most recent earnings report (2024-08-02) showed EPS of 4.05, beating the analysts' estimates.
*   Revenue for the quarter came in at $10.54 billion, exceeding analysts' expectations.

**5.  News and Recent Issues:**

*   **Recent Earnings Release:** Thermo Fisher Scientific Inc. announced its Q2 2024 earnings report on August 2nd, 2024, exceeding analysts' expectations on both EPS and revenue.
*   **Recent Market Outlook:** Thermo Fisher Scientific Inc. remains a strong player in the life sciences and diagnostics industry, with continued growth expected in the coming years.
*   **Analyst Opinions and Performance Highlights:** The stock is currently rated as "Buy" by most analysts, with a consensus price target slightly above the current market price. 

**6.  Overall Analysis:**

Thermo Fisher Scientific Inc. has historically outperformed the S&P 500, and recent earnings reports continue to demonstrate strong growth. While the stock is currently experiencing a short-term downward trend, its overall long-term prospects remain positive, with a strong expected return potential exceeding the S&P 500. 

**7.  Conclusion:**

TMO is a solid investment with a strong history of performance and a promising future outlook. The current downward trend presents a potential buying opportunity for investors seeking long-term exposure to the life sciences and diagnostics industry. However, it is always advisable to conduct further research and consult with a financial advisor before making any investment decisions.
